The Long and Winding Road for New Treatments for Acquired Thrombotic Thrombocytopenic Purpura

por Schutgens, Roger E.G.
Publicado 2019

FXII: The Cuckoo in the Nest

por Schutgens, Roger E.G.
Publicado 2018

Stay Tuned on Statins: The New Panacea?

por Schutgens, Roger E.G.
Publicado 2018

High Five for Low Five

por Schutgens, Roger E.G.
Publicado 2020

Gene Therapy for Hemophilia A: How Long Will It Last?

por Schutgens, Roger E. G.
Publicado 2022

First-line Therapy for Immune Thrombocytopenia: Time for Change

por Schutgens, Roger E. G.
Publicado 2022

Aptamers Targeting Von Willebrand Factor: What and Why?

por Schutgens, Roger E. G.
Publicado 2023

Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective

por Schutgens, Roger E.G., Middeldorp, Saskia
Publicado 2023

Tranexamic Acid Is Not a Universal Hemostatic Agent

por Schutgens, Roger E. G., Lisman, Ton
Publicado 2021

Glanzmann thrombasthenia complicated by frequent myeloproliferative neoplasm‐related thromboembolism: thrombosis occurring regardless of αIIbβIII integrin deficiency

por Schutgens, Roger E. G., Urbanus, Rolf T.
Publicado 2021

Relapse of immune thrombocytopenia after COVID‐19 vaccination

por van Dijk, Wobke E. M., Schutgens, Roger E. G.
Publicado 2021

Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A

por Schep, Sarah J., Schutgens, Roger E. G., Fischer, Kathelijn, Voorberg, Jan, Boes, Marianne
Publicado 2021

The Paediatric Haemophilia Activities List (pedHAL) in routine assessment: changes over time, child‐parent agreement and informative domains

por Kuijlaars, Isolde A. R., van der Net, Janjaap, Schutgens, Roger E. G., Fischer, Kathelijn
Publicado 2019

Coordinating physiotherapy care for persons with haemophilia

por Timmer, Merel A., Blokzijl, Johan, Schutgens, Roger E. G., Veenhof, Cindy, Pisters, Martijn F.
Publicado 2021

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

por Leentjens, Jenneke, van Haaps, Thijs F, Wessels, Pieter F, Schutgens, Roger E G, Middeldorp, Saskia
Publicado 2021

Possible Targets to Reduce Fatigue in Chronic Immune Thrombocytopenia Patients – An Explorative Study

por van Dijk, Wobke E.M., Nap-van der Vlist, Merel M., Knoop, Hans, Schutgens, Roger E.G.
Publicado 2022

Catheter Ablation for Atrial Fibrillation in Patients with Hemophilia or von Willebrand Disease

por van der Valk, Paul R., Mauser-Bunschoten, Eveline P., van der Heijden, Jeroen F., Schutgens, Roger E. G.
Publicado 2019

Movement behaviour patterns in adults with haemophilia

por Timmer, Merel A., Veenhof, Cindy, de Kleijn, Piet, de Bie, Rob A., Schutgens, Roger E. G., Pisters, Martijn F.
Publicado 2020

Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database

por Versloot, Olav, Iserman, Emma, Chelle, Pierre, Germini, Federico, Edginton, Andrea N., Schutgens, Roger E. G., Iorio, Alfonso, Fischer, Kathelijn
Publicado 2021

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

por Versloot, Olav, Iserman, Emma, Chelle, Pierre, Germini, Federico, Edginton, Andrea N., Schutgens, Roger E. G., Iorio, Alfonso, Fischer, Kathelijn
Publicado 2022